SCHEMBL20066492

SCHEMBL20066492

CCc1c(F)cc(C#C[Si](C)(C)C)cc1F

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
LOX P28300 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28416773 0.83 FFAR1 (0.35) FFAR1FFAR4LOX
SCHEMBL23213745 0.82 FFAR1 (0.36) FFAR1FFAR4
SCHEMBL7526965 0.79 LOX (0.31) LOX
SCHEMBL19677742 0.78 HDAC1 (0.31) LOX
SCHEMBL6180715 0.77 FFAR1 (0.41) FFAR1FFAR4
SCHEMBL19781323 0.76 KDM1A (0.34)
SCHEMBL20929147 0.76 LOX (0.32) LOX
SCHEMBL19781318 0.76
SCHEMBL19895097 0.74
SCHEMBL22439969 0.74 GABRA1 (0.33) LOX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180104220-A1 IMIDAZOLE COMPOUND MEDSHINE DISCOVERY INC. (CN) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180104220-A1 IMIDAZOLE COMPOUND MAPT, SLC10A2, SLC5A11 FFAR1 4606/4885FFAR4 4464/4885LOX 3906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.